Case Study:
Using Large Language Models (LLMs) like ChatGPT to Speed Up Medical Literature Monitoring and Insights
How Large Language Models are helping medical affairs teams increase productivity and reduce medical literature monitoring time
The fastest growing bodies of content—in both volume and complexity—are in life sciences and healthcare. Analyzing this content (including clinical studies, publications, guidelines and more) and for medical insights will drive better decisions.
The Client
The client was spending significant time keeping up to date with monitoring and evaluating new medical content. This was a very resource-intense activity and they wanted a way to automate part of this.
The Solution
Using data-driven Natural Language Intelligence (including LLMs) to combine scale and flexibility with contextual understanding, and precision to provide content intelligence for deeper understanding and efficiency.
The Outcome
- Significant Increase in productivity (average from client estimate following implementation is 1000%)
- Significant decrease in literature monitoring time (average from client estimate following implementation is 82-92%)
- Vastly improved tracking to support portfolio products
To achieve these kinds of results, contact Eularis today.

Latest News
Read our latest blogs here.

Why Generative AI Prompts Fail
Introduction Generative AI is revolutionizing the pharmaceutical industry, offering unparalleled opportunities to accelerate drug discovery, optimize clinical trials, and refine patient care strategies. Yet, amidst

AI Success Demands Strategy: Avoid the Trap of Random Experiments
In the high-stakes world of pharmaceuticals, AI holds incredible promise.It offers the potential to speed up drug discovery, improve clinical trials, transform patient care, etc.

How Pharma Companies Can Build Trustworthy AI Agents
In an industry where a single miscalculation can impact millions of lives, pharmaceutical companies are witnessing an unprecedented transformation through AI agents – autonomous systems